Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 10, 2012
Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imagingH Quon, D A Loblaw, P C F Cheung, et al.
Physics in Medicine and Biology|February 12, 2008
Megavoltage cone beam digital tomosynthesis (MV-CBDT) for image-guided radiotherapy: a clinical investigational systemG Pang, A Bani-Hashemi, P Au, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 24, 2009
Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II studyA Hird, L Zhang, T Holt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 14, 2017
Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate CancerN Shahid, A Loblaw, H T Chung, et al.
British Journal of Cancer|December 1, 1995
Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptakeL D Skarsgard, D K Acheson, A Vinczan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 17, 2017
Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost-Utility AnalysisJ Helou, S Torres, H B Musunuru, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 8, 2008
Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3C I Tang, D A Loblaw, P Cheung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 11, 2020
Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory studyH Wang, L C Mendez, G Morton, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 27, 2021
Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT AnalysisR M Glicksman, A U Kishan, A J Katz, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 18, 2008
A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagusZ Kassam, R K S Wong, J Ringash, et al.
Pageof 5